Core Viewpoint - The article discusses the innovative use of hydrogel as a treatment for intrauterine adhesions (IUA), highlighting its potential to improve endometrial repair and fertility recovery through the incorporation of human umbilical cord mesenchymal stem cells and nitric oxide receptor stimulators [1][10]. Group 1: Research Background - IUA is a common complication following endometrial damage, and traditional treatments struggle to achieve simultaneous structural and functional repair of the endometrium [1]. - The research led by Professor Zhou Qian from the Shanghai First Maternity and Infant Health Hospital focuses on addressing the clinical challenge of IUA [1]. Group 2: Research Findings - The study published in Acta Biomaterialia explores the synergy between injectable HA/Gel hydrogel and human umbilical cord mesenchymal stem cells in animal models, providing new insights into preclinical treatment options for endometrial repair and fertility recovery [1][9]. - A novel injectable hydrogel loaded with nitric oxide receptor stimulators was designed to effectively promote endometrial repair in IUA patients, addressing the common issue of insufficient nitric oxide levels [1][10]. Group 3: Upcoming Online Lecture - An online lecture featuring Dr. Zhang Donghai, the first author of the research, is scheduled for December 23, 2025, focusing on the research design, key data, and innovative logic behind the hydrogel treatment for IUA [2][5]. - The lecture aims to provide insights into designing scientifically and practically viable hydrogel treatment strategies, including cell/drug loading strategies and mechanism validation [2][7].